Pfizer says FDA rejects osteoporosis drug
13th Sep 2005, 22:09 GMT
NEW YORK (Reuters) - Pfizer Inc. on Tuesday said U.S. regulators denied approval of its experimental osteoporosis drug Oporia, handing the world's biggest drug maker another setback in its efforts to bring lucrative, new medicines to market.
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study